Boc-L-norvaline N-hydroxysuccinimide ester, 98.0%, 5g

3-Benzofurancarboxylic acid, 4-[(1E)-3-[(1R)-1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxo-1-propen-1-yl]-2-(3,4-dihydroxyphenyl)-2,3-dihydro-7-hydroxy-, (2S,3S)-, 95%, 50mg

((4-(o-tolyloxy)phenyl)sulfonyl)glycine, 95.0%, 1g

4-Chloro-2-(trifluoromethyl)benzaldehyde, 97.0%, 1g

Methyl 4-amino-2-methylbenzoate, 97.0%, 25g

N,N-Diethylhydroxylamine>98.0%(GC)(T)100mL

Imidazo[1,2-a]pyrimidin-7-amine, 97%, 1g

6-BROMO-1,3,3-TRIMETHYLINDOLIN-2-ONE, 95.0%, 10g

4-AMINO-6-FLUORONICOTINIC ACID, 95.0%, 1g

1,1,3,3,5,5,7,7,9,9,11,11,13,13,15,15-Hexadecamethyloctasiloxane, 98%, 250mg

2-AMINO-2-(3-BROMOPHENYL)ETHAN-1-OL, 95.0%, 1g

2,4-difluoro-N-methoxy-N-methylbenzamide, 97%, 500mg

2-Chloro-6-propylpyridine, 98%, 500mg